ESCRS - PO568 - A Single-Center, Prospective, Observational Study To Evaluate Visual Outcomes And Patient Satisfaction After Acrysofvivity Iol Implantation In Patients With Mild Irregular Astigmatism

A Single-Center, Prospective, Observational Study To Evaluate Visual Outcomes And Patient Satisfaction After Acrysofvivity Iol Implantation In Patients With Mild Irregular Astigmatism

Published 2024 - 42nd Congress of the ESCRS

Reference: PO568 | Type: Free paper | DOI: 10.82333/gytn-3q15

Authors: Ashvin Agarwal* 1 , Soundari S 1 , Triveni V 1 , Uma Maheswari M 2 , Abarna lakshmi R 2

1Ophthalmology,Dr Agarwals Eye Hospital,Chennai,India, 2clinical research,Dr Agarwals Eye Hospital,Chennai,India

Purpose

To evaluate the visual outcomes following implantation of Vivity IOL in patients with mild irregular astigmatism. This study aims to find if AcrySofVivity IOL can provide spherical correction for most working distances in patients with mild irregular astigmatism, thus reducing dependency on glasses in such patients without causing significant visual disturbances.

Setting

This is a single center, prospective, single arm observational study in patients with irregular astigmatism who have been implanted with AcrySofVivity IOL. The entire study lasts for seven to eight months. This involves three months of recruitment period, three months of study period and one month of data compilation and analysis

Methods

This study includes 30 eyes from subjects aged ≥ 45 years. Patients with age related cataract and mild irregular corneal astigmatism defined as mean keratometry values ≤ 47 D, Keratoconus Index showing superior- inferior asymmetry ≤ 1.4 D, Surface Regularity Index 0.56 to 1.55, CCT 500 to 560 µm with unilateral or bilateral implantation of AcrySofVivity IOL will participate in the study. Patients with astigmatism > 0.75 D, ocular co-morbidities, participation in other investigational study will be excluded. Manifest refraction and monocular Visual Acuity (VA) at 6, 66 and 40 cm will be recorded at month 1 and 3 post-op visit. Subjects will complete Patient Reported Spectacle Independence Questionnaire (PRISQ) and VF-14 QOL at month 3 visit.

Results

The primary outcome will be monocular best corrected distance visual acuity. Secondary outcomes include monocular uncorrected visual acuity (distance, intermediate, near), monocular distance corrected intermediate visual acuity, distance corrected near visual acuity, exploratory endpoints PRISQ and VF-14 QOL. Descriptive and inferential statistics will be used to analyse the outcomes.

Conclusions

We expect that AcrySofVivity IOL implantation will result in improvement in visual acuity and increased level of spectacle independence and patient satisfaction of visual functions